Literature DB >> 16517858

Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism.

M Machouart1, J Larché, K Burton, J Collomb, P Maurer, A Cintrat, M F Biava, S Greciano, A F A Kuijpers, N Contet-Audonneau, G S de Hoog, A Gérard, B Fortier.   

Abstract

Mucormycosis is a rare and opportunistic infection caused by fungi belonging to the order Mucorales. Recent reports have demonstrated an increasing incidence of mucormycosis, which is frequently lethal, especially in patients suffering from severe underlying conditions such as immunodeficiency. In addition, even though conventional mycology and histopathology assays allow for the identification of Mucorales, they often fail in offering a species-specific diagnosis. Due to the lack of other laboratory tests, a precise identification of these molds is thus notoriously difficult. In this study we aimed to develop a molecular biology tool to identify the main Mucorales involved in human pathology. A PCR strategy selectively amplifies genomic DNA from molds belonging to the genera Absidia, Mucor, Rhizopus, and Rhizomucor, excluding human DNA and DNA from other filamentous fungi and yeasts. A subsequent digestion step identified the Mucorales at genus and species level. This technique was validated using both fungal cultures and retrospective analyses of clinical samples. By enabling a rapid and precise identification of Mucorales strains in infected patients, this PCR-restriction fragment length polymorphism-based method should help clinicians to decide on the appropriate treatment, consequently decreasing the mortality of mucormycosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517858      PMCID: PMC1393117          DOI: 10.1128/JCM.44.3.805-810.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult.

Authors:  T Solano; B Atkins; E Tambosis; S Mann; T Gottlieb
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

Review 2.  Mucormycoses.

Authors:  J Eucker; O Sezer; B Graf; K Possinger
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

3.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

4.  Mucormycosis in hematologic malignancies: an emerging fungal infection.

Authors:  A Nosari; P Oreste; M Montillo; G Carrafiello; M Draisci; G Muti; A Molteni; E Morra
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

5.  Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy.

Authors:  Angela Ma Tobón; Myrtha Arango; Darío Fernández; Angela Restrepo
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

6.  18S rRNA gene variation among common airborne fungi, and development of specific oligonucleotide probes for the detection of fungal isolates.

Authors:  Zhihong Wu; Yoshihiko Tsumura; Göran Blomquist; Xiao-Ru Wang
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

7.  Diagnosis of cutaneous mucormycosis due to Rhizopus microsporus by an innovative PCR-restriction fragment-length polymorphism method.

Authors:  J Larché; M Machouart; K Burton; J Collomb; M F Biava; A Gérard; B Fortier
Journal:  Clin Infect Dis       Date:  2005-11-01       Impact factor: 9.079

Review 8.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

9.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  In vitro susceptibilities of zygomycetes to conventional and new antifungals.

Authors:  Eric Dannaoui; Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

View more
  26 in total

1.  Real-time PCR method for detection of zygomycetes.

Authors:  D Jane Hata; Seanne P Buckwalter; Bobbi S Pritt; Glenn D Roberts; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

2.  Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi.

Authors:  N Esther Babady; Edwin Miranda; Kathleen A Gilhuley
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

3.  In Vitro Activity of Combinations of Zinc Chelators with Amphotericin B and Posaconazole against Six Mucorales Species.

Authors:  Florencia Leonardelli; Daiana Macedo; Catiana Dudiuk; Laura Theill; Matias S Cabeza; Soledad Gamarra; Guillermo Garcia-Effron
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 4.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 5.  Challenges in the diagnosis and treatment of mucormycosis.

Authors:  A Skiada; C Lass-Floerl; N Klimko; A Ibrahim; E Roilides; G Petrikkos
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

6.  Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation.

Authors:  Eric Dannaoui; Patrick Schwarz; Michal Slany; Juergen Loeffler; Anne Tomine Jorde; Manuel Cuenca-Estrella; Philippe M Hauser; Raghdaa Shrief; Michel Huerre; Tomas Freiberger; Peter Gaustad; Juan-Luis Rodriguez-Tudela; Jacques Bille; David W Denning; Stéphane Bretagne; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

7.  Identification of fungal pathogens in a patient with acute myelogenic leukemia using a pathogen detection array technology.

Authors:  Sagarika Banerjee; Kristen N Peck; Michael D Feldman; Mindy G Schuster; James C Alwine; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

8.  Outbreak of intestinal infection due to Rhizopus microsporus.

Authors:  Vincent C C Cheng; Jasper F W Chan; Antonio H Y Ngan; Kelvin K W To; S Y Leung; H W Tsoi; W C Yam; Josepha W M Tai; Samson S Y Wong; Herman Tse; Iris W S Li; Susanna K P Lau; Patrick C Y Woo; Anskar Y H Leung; Albert K W Lie; Raymond H S Liang; T L Que; P L Ho; K Y Yuen
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

9.  Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.

Authors:  Miki Kasai; Susan M Harrington; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Mara G Beveridge; Tena Knudsen; Jeffery Milanovich; Margaret P Cotton; Johanna Hughes; Robert L Schaufele; Tin Sein; John Bacher; Patrick R Murray; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

10.  Isolation and characterization of a strain of Lichtheimia corymbifera (ex Absidia corymbifera) from a case of bovine abortion.

Authors:  Chiara Piancastelli; Francesca Ghidini; Gaetano Donofrio; Stefano Jottini; Simone Taddei; Sandro Cavirani; Clotilde S Cabassi
Journal:  Reprod Biol Endocrinol       Date:  2009-11-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.